BVN vs. ZVRA

Last updated Jun 13, 2026

BVN (Compañía de Minas Buenaventura S.A.A.) and ZVRA (Zevra Therapeutics Inc.) are both stocks. BVN operates in Other Precious Metals & Mining (Basic Materials), while ZVRA operates in Biotechnology (Healthcare). Over the past 10 years, BVN returned 13.54%/yr vs -16.40%/yr for ZVRA. At a 0.08 correlation, their price movements are largely independent.

Performance

BVN vs. ZVRA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Compañía de Minas Buenaventura S.A.A. (BVN) and Zevra Therapeutics Inc. (ZVRA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BVN achieves a 23.58% return, which is significantly lower than ZVRA's 41.18% return. Over the past 10 years, BVN has outperformed ZVRA with an annualized return of 13.54%, while ZVRA has yielded a comparatively lower -16.40% annualized return.

BVN

• 1D: 2.01%
• 1M: -13.13%
• YTD: 23.58%
• 6M: 22.13%
• 1Y: 105.88%
• 3Y*: 70.14%
• 5Y*: 27.27%
• 10Y*: 13.54%

ZVRA

• 1D: -2.47%
• 1M: 13.76%
• YTD: 41.18%
• 6M: 51.86%
• 1Y: 35.01%
• 3Y*: 29.54%
• 5Y*: -2.85%
• 10Y*: -16.40%

*Multi-year figures are annualized to reflect compound growth (CAGR)

BVN vs. ZVRA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
BVN Compañía de Minas Buenaventura S.A.A.	23.58%	147.96%	-24.06%	106.47%	2.47%	-39.95%	-19.27%	-6.40%	15.91%	25.66%
ZVRA Zevra Therapeutics Inc.	41.18%	7.43%	27.33%	42.70%	-47.30%	-22.23%	84.70%	-78.71%	-56.05%	37.29%

Correlation

The correlation between BVN and ZVRA is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.12
Correlation (3Y) Calculated over the trailing 3-year period	0.11
Correlation (5Y) Calculated over the trailing 5-year period	0.08
Correlation (10Y) Calculated over the trailing 10-year period	0.07
Correlation (All Time) Calculated using the full available price history since Apr 16, 2015	0.08

Fundamentals

Market Cap BVN : $8.49B ZVRA : $761.92M
EPS BVN : $3.84 ZVRA : $2.16
PE Ratio BVN : 8.69 ZVRA : 5.85
PS Ratio BVN : 4.15 ZVRA : 5.94
PB Ratio BVN : 2.05 ZVRA : 3.70
Total Revenue (TTM) BVN : $2.05B ZVRA : $122.29M
Gross Profit (TTM) BVN : $1.06B ZVRA : $104.94M
EBITDA (TTM) BVN : $1.18B ZVRA : $149.15M

Return for Risk

BVN vs. ZVRA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BVN

BVN Risk / Return Rank: 86
BVN Sharpe Ratio Rank: 90
BVN Sortino Ratio Rank: 84
BVN Omega Ratio Rank: 85
BVN Calmar Ratio Rank: 87
BVN Martin Ratio Rank: 86

ZVRA

ZVRA Risk / Return Rank: 60
ZVRA Sharpe Ratio Rank: 61
ZVRA Sortino Ratio Rank: 62
ZVRA Omega Ratio Rank: 61
ZVRA Calmar Ratio Rank: 60
ZVRA Martin Ratio Rank: 57

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BVN vs. ZVRA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Compañía de Minas Buenaventura S.A.A. (BVN) and Zevra Therapeutics Inc. (ZVRA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	BVN	ZVRA	Difference
Sharpe ratio: Return per unit of total volatility	2.12	0.56	+1.56
Sortino ratio: Return per unit of downside risk	2.45	1.27	+1.18
Omega ratio: Gain probability vs. loss probability	1.34	1.16	+0.18
Calmar ratio: Return relative to maximum drawdown	3.48	0.81	+2.67
Martin ratio: Return relative to average drawdown	8.76	1.41	+7.35

BVN vs. ZVRA - Sharpe Ratio Comparison

The current BVN Sharpe Ratio is 2.12, which is higher than the ZVRA Sharpe Ratio of 0.56. The chart below compares the historical Sharpe Ratios of BVN and ZVRA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

BVN vs. ZVRA - Drawdown Comparison

The maximum BVN drawdown since its inception was -93.68%, smaller than the maximum ZVRA drawdown of -99.27%. Use the drawdown chart below to compare losses from any high point for BVN and ZVRA.

Drawdown Indicators

	BVN	ZVRA	Difference
Max Drawdown Largest peak-to-trough decline	-93.68%	-99.27%	+5.59%
Max Drawdown (1Y) Largest decline over 1 year	-30.64%	-43.47%	+12.83%
Max Drawdown (3Y) Largest decline over 3 years	-38.30%	-43.47%	+5.17%
Max Drawdown (5Y) Largest decline over 5 years	-53.67%	-74.01%	+20.34%
Max Drawdown (10Y) Largest decline over 10 years	-70.15%	-97.85%	+27.70%
Current Drawdown Current decline from peak	-31.25%	-96.65%	+65.40%
Average Drawdown Average peak-to-trough decline	-46.40%	-86.41%	+40.01%
Ulcer Index Depth and duration of drawdowns from previous peaks	12.13%	24.87%	-12.74%

Volatility

BVN vs. ZVRA - Volatility Comparison

The current volatility for Compañía de Minas Buenaventura S.A.A. (BVN) is 20.09%, while Zevra Therapeutics Inc. (ZVRA) has a volatility of 24.56%. This indicates that BVN experiences smaller price fluctuations and is considered to be less risky than ZVRA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BVN	ZVRA	Difference
Volatility (1M) Calculated over the trailing 1-month period	20.09%	24.56%	-4.47%
Volatility (6M) Calculated over the trailing 6-month period	42.55%	40.23%	+2.32%
Volatility (1Y) Calculated over the trailing 1-year period	50.28%	62.90%	-12.62%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	45.80%	60.49%	-14.69%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	45.95%	81.46%	-35.51%

Dividends

BVN vs. ZVRA - Dividend Comparison

BVN's dividend yield for the trailing twelve months is around 3.40%, while ZVRA has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
BVN Compañía de Minas Buenaventura S.A.A.	3.40%	1.57%	0.63%	0.48%	0.98%	0.00%	0.00%	0.58%	0.55%	0.60%	0.26%
ZVRA Zevra Therapeutics Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both BVN and ZVRA in my portfolio?

BVN and ZVRA have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BVN or ZVRA?

ZVRA has higher volatility (24.56%) compared to BVN (20.09%). In terms of maximum drawdown, BVN dropped -93.68% vs ZVRA's -99.27%.

Which has better risk-adjusted returns?

BVN currently has the higher Sharpe Ratio (2.12 vs 0.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.